Biomea Fusion is trading 5.83% up at $1.91, most likely reflecting biotech-sector momentum.
- Shares extended the September 1 close of $1.80, when they gained 7.14%.
- No new company-specific announcement dated September 2, 2026, was identified on the investor-relations site, which shows only stock-quote information.
- XBI is up 2.75%, while major U.S. indexes show modest gains, indicating a sector-driven move rather than a company-specific catalyst.